Home › NDC Lookup › Ingredients › Avobenzone Homosalate Octisalate Octocry... › 84130-0000-00
Kopari Sunglaze Sheer Body Mist Sunscreen SPF42 AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE 30 mg/mL; 5 mg/mL; 50 mg/mL; 100 mg/mL Spray, 140 mL — NDC 84130-0000-00 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Kopari Sunglaze Sheer Body Mist Sunscreen SPF42 AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE 30 mg/mL; 5 mg/mL; 50 mg/mL; 100 mg/mL Spray, 140 mL — NDC 84130-000-00 (Billing 84130-0000-00)

by Kopari Beauty · 140 mL in 1 BOTTLE

This is a package of 140 mL of Kopari Sunglaze Sheer Body Mist Sunscreen SPF42 AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE 30 mg/mL; 5 mg/mL; 50 mg/mL; 100 mg/mL Spray from Kopari Beauty, marketed since Feb 2024 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 84130-0000-00
🏷️ FDA NDC (as labeled) 84130-000-00 billing pads the product segment with a zero
This package
Contains140 mL Pack sizes2 compare ↓
Main listing for product 84130-000 · Also comes in: 60 ml 84130-000-20
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 84130-000-00 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
84130 labeler · 000 product · 00 package
Package marketed since
Feb 5, 2024
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 8413000000 1
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 84130-000-00
Product NDC 84130-000
11-digit billing NDC 84130000000
UNII G63QQF2NOX, V06SV4M95S, 4X49Y0596W, 5A68WGF6WM
Application # M020
SPL Set ID 7c96b799-e24d-473f-8f0a-3fad83d5ed48
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2024-02-05
Route TOPICAL
Dosage form SPRAY
Substance AVOBENZONE; HOMOSALATE; OCTISALATE; OCTOCRYLENE
Why two NDCs? The FDA registers this code as 84130-000-00 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 84130-0000-00. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

Clinical

🧪 What is this product?

Kopari Sunglaze Sheer Body Mist Sunscreen is a spray-applied sunscreen product designed for topical use on the skin. It contains four ultraviolet (UV) filter ingredients: avobenzone, homosalate, octisalate, and octocrylene, which are commonly used together in sunscreen formulations to absorb and scatter ultraviolet rays from the sun. This is an over-the-counter monograph drug, meaning it is marketed under FDA's established rules for sunscreen products rather than through individual product approval. The mist delivery system provides a convenient application method for broad-body sun protection.

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer mLPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 60 ml
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
84130-0000-00 You're viewing this Main listing 140 mL in 1 BOTTLE 2024-02-05 — Active
84130-0000-20 84130-000-20 60 mL in 1 BOTTLE, PUMP 2025-12-12 — Active

You're viewing the largest of 2 pack sizes for this product.

Pack size FAQ

What quantity is in this package?
This package contains 140 mL — 140 ml in 1 bottle.
How does this package differ from NDC 84130-0000-20?
Both are Kopari Sunglaze Sheer Body Mist Sunscreen SPF42 AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE 30 mg/mL; 5 mg/mL; 50 mg/mL; 100 mg/mL Spray — the drug itself is identical. This page's package is the 140 mL one, while NDC 84130-0000-20 is the 60 ml package.
What NDC number is used to bill for this package of Kopari Sunglaze Sheer Body Mist Sunscreen SPF42 AVOBENZONE, HOMOSALATE, OCTISALATE, OCTOCRYLENE 30 mg/mL; 5 mg/mL; 50 mg/mL; 100 mg/mL Spray?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Golden Sunglaze Sheer Body Mist Sunscreen SPF50 30 mg/mL; 5 mg/mL; 50 mg/mL; 100 mg/mL 84130-0012-50 Koco 150 ml — — FDA listed —
Kopari Sunglaze Sheer Body Mist Sunscreen SPF42 30 mg/mL; 5 mg/mL; 50 mg/mL; 100 mg/mLthis 84130-0000-00 Kopari 140 ml — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2024
On the market since
Feb 2024
📍
2026
Currently FDA-listed
2 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 7X6O37OK2I
    A synthetic fragrance compound used as a flavoring agent or aromatic component in medicines. It adds pleasant taste or smell to make the medication more acceptable to patients.
  • UNII 3K9958V90M
    A liquid solvent derived from fermentation or chemical synthesis. In medicines, alcohol dissolves active ingredients, helps preserve the product, and improves how the body absorbs certain drugs.
  • UNII A9EJ3J61HQ
    A synthetic liquid derived from benzoic acid and long-chain alcohols. It functions as a solvent and penetration enhancer in topical formulations, helping active ingredients dissolve and absorb into the skin.
  • UNII WAO5MNK9TU
    Benzyl salicylate is a fragrant chemical compound used as a flavor and scent ingredient in medicines. It helps mask unpleasant tastes or odors in liquid or oral formulations.
  • UNII 2EH13UN8D3
    A synthetic compound used as a solvent and penetration enhancer in topical formulations. It helps dissolve active ingredients and allows them to penetrate the skin more effectively.
  • UNII D5340Y2I9G
    Castor oil is a natural plant-based oil used in medicines as a lubricant, laxative agent, and solvent. It helps medicine ingredients dissolve or flow smoothly and can aid bowel movement in formulations designed for that purpose.
  • UNII 4X371TMK9K
    Dibutyl maleate is a synthetic chemical compound used as a plasticizer and solvent in pharmaceutical formulations. It helps soften and improve the flexibility of coatings and film-forming ingredients in medicines.
  • UNII 609A3V1SUA
    A silky liquid derived from caprylic acid that acts as an emollient and solvent in formulations. It helps dissolve active ingredients and improves the spreadability and feel of lotions, creams, and topical products.
  • UNII P7E6YFV72X
    Diisopropyl adipate is a clear, oily liquid derived from adipic acid. It acts as a plasticizer and solvent in medicines, helping soften coatings and improve how the drug dissolves or spreads in the body.
  • UNII 1K09F3G675
    Ferric oxide red is an inorganic iron compound used as a colorant in medicines. It gives tablets, capsules, or other dosage forms a red or reddish tint for identification and appearance.
  • UNII YSE9PPT4TH
    Hyaluronate sodium is a natural carbohydrate that holds moisture. It's used in medicines as a lubricant, thickener, and moisture-retaining agent to improve texture and delivery of the active ingredient.
  • UNII ZF94AP8MEY
    Hydrogenated castor oil is a processed plant oil made by adding hydrogen to castor oil. It's used as a binder to help hold tablet ingredients together and as a lubricant to prevent sticking during manufacturing.
  • UNII D81QY6I88E
    Linalool is a natural fragrant oil found in plants like lavender and citrus. It's used in medicines as a flavoring agent and to mask unpleasant tastes or smells.
  • UNII V8A1AW0880
    Mica is a naturally occurring mineral that's ground into fine powder. It's used in medicines as a colorant and anti-caking agent to improve appearance and prevent clumping in tablets or powders.
  • UNII KM7N50LOS6
    Tin oxide is an inorganic mineral compound used in medicines as a colorant and opacifying agent. It provides white or off-white color to tablets, capsules, and coatings while helping make formulations less transparent.
  • UNII MD83SFE959
    A volatile organic liquid used as a solvent and preservative in medications. It helps dissolve active ingredients and other components, and can improve product stability and shelf life.
  • UNII 9LBV3F07AZ
    A synthetic, oil-soluble form of vitamin C used as an antioxidant to prevent degradation of the medicine and maintain its stability during storage.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.
  • UNII R0ZB2556P8
    Tocopherol is a form of vitamin E derived from plant oils. It acts as an antioxidant in medicines to prevent oils and fats from breaking down and spoiling during storage.

19 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesAlcohol Denat., C12-15 Alkyl Benzoate, Butyloctyl Salicylate, Diisopropyl Adipate, Sodium Hyaluronate, Tocopherol, Hydrogenated Castor Oil, Tetrahexyldecyl Ascorbate, Ricinus Communis (Castor) Seed Oil, Dicaprylyl Carbonate, VA/Butyl Maleate/Isobornyl Acrylate Copolymer, Fragrance (Parfum), Mica, T-Butyl Alcohol, Tin Oxide, Hexyl Cinnamal, Benzyl Salicylate, Linalool, CI 77891 (Titanium Dioxide), CI 77491 (Iron Oxides).

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerKopari Beauty
FDA applicationM020 (OTC MONOGRAPH DRUG)
Labeler code84130
First marketedFeb 2024
Product typeHuman Otc Drug

More NDCs from Kopari Beauty labeler code 84130

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 29 words ▾

Uses Helps prevent sunburn If used as directed with other sun protection measures (see Directions), decreases the risk of skin cancer & early skin aging caused by the sun.

⏱️ Dosage and Administration 106 words ▾

Directions Shake well before dispensing. Spray directly onto skin. For Sunscreen use: Apply generously and evenly 15 minutes before sun exposure.

Reapply After 80 minutes of swimming or sweating. Immediately after towel drying. At least every 2 hours Sun Protection Measures: Spending time in the sun increases your risk of skin cancer & early skin aging.

To decrease this risk, regularly use a sunscreen with a Broad Spectrum SPF value of 15 or higher & other sun protection measures including: Limit time in the sun, especially from 10 a.m. - 2 p.m Wear long-sleeved shirts, pants, hats and sunglasses Children under 6 months: Ask a doctor

⚠️ Warnings 52 words ▾

Warnings For external use only Do not use on damaged or broken skin Do not spray in eyes. If contact occurs, rinse well with water. If irritation persists, consult a doctor. Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 14 words ▾

Active ingredients Avobenzone 3 % Homosalate 0.5 % Octisalate 5% Octocrylene 10% Purpose Sunscreen

🧪 Inactive Ingredients 50 words ▾

Inactive Ingredients Alcohol Denat., C12-15 Alkyl Benzoate, Butyloctyl Salicylate, Diisopropyl Adipate, Sodium Hyaluronate, Tocopherol, Hydrogenated Castor Oil, Tetrahexyldecyl Ascorbate, Ricinus Communis (Castor) Seed Oil, Dicaprylyl Carbonate, VA/Butyl Maleate/Isobornyl Acrylate Copolymer, Fragrance (Parfum), Mica, T-Butyl Alcohol, Tin Oxide, Hexyl Cinnamal, Benzyl Salicylate, Linalool, CI 77891 (Titanium Dioxide), CI 77491 (Iron Oxides).

🎯 Purpose 2 words ▾

Purpose Sunscreen

📄 Do Not Use 26 words ▾

Do not use on damaged or broken skin Do not spray in eyes. If contact occurs, rinse well with water. If irritation persists, consult a doctor.

📄 Keep Out of Reach of Children 21 words ▾

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 4 words ▾

Questions/Comments Call (858) 252-0099

📄 Package Label / Principal Display Panel 6 words ▾

Package Labeling: Outer Package Label 1

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Kopari Sunglaze Sheer Body Mist Sunscreen SPF42 (this brand).

Top reported reactions

Acute Myeloid Leukaemia2
Exposure To Toxic Agent2
Product Contamination Chemical2
Rash2
Anaphylactic Reaction1
Application Site Erythema1
Application Site Exfoliation1

Reporter sex

0 reports
Male · 20%
Female · 80%

Serious outcomes

Life-threatening1
Death1
Reports over time (by year) — tap or hover for the count & year
2025 2026 1 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Kopari Beauty. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 60 ml (84130-0000-20). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Kopari Beauty is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 84128-0014-03 · XINXIANG 84130-0001-10 · Koco →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.